As birth rates increase across both developed and developing countries, coupled with the rising incidence of paediatric ...

Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

The modular, scalable monitoring platform offers a range of physiological measurements, including Masimo SET ® pulse oximetry, measure-on-inflation noninvasive blood pressure, continuous ...

Masimo (NASDAQ: MASI) today announced that Vanderbilt University Medical Center (VUMC), a renowned healthcare facility in Nashville, Tennessee, is piloting the use of the Masimo Radius VSM ...

Apple convinced a federal jury on Friday that early versions of health monitoring tech company Masimo's smartwatches ... which is worth about $3.5 trillion, just $250 in damages - the statutory ...

The lawsuit resulted in five of Masimo’s claims being rejected, and a jury being unable to reach agreement on the rest. That will see a new trial held, at a date yet to be set. Masimo got its ...

A jury in Delaware awarded Apple $250, concluding that Masimo's older smartwatch designs infringed on Apple's design patents. The jury determined the infringement was intentional, but the verdict ...

A Delaware jury has found health tech company Masimo guilty of infringing Apple’s Apple Watch patents on health technology, but limited it to only older smartwatch models that are no longer sold, and ...

Instead, Apple, valued at $3.5 trillion, sought to secure a strategic advantage by pressing for an injunction on the sales of Masimo’s latest smartwatch ... tech giants and health technology firms are ...